2m 2m 2m 2m 2m 2m 2m
ABEONA THERAP (ABEO)
NASDAQ
$5.09+$0.08 (+1.66%)
Price as of Oct 02, 2026 5:18 PM EDT- $286.5MMarket Cap
- -5.83%1-Year Change
- BiotechnologyIndustry
ABEONA THERAP (ABEO)
$5.09+$0.08 (+1.66%)
ABEO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.01 | ||
Change | -$0.24 (-4.57%) | ||
Open | $5.22 | ||
High | $5.25 | ||
Low | $4.99 | ||
Previous Close | $5.25 | ||
Volume | 1,475,812 | ||
30-Day Average Volume | 1,411,917 | ||
1-Week Change | -7.73% | ||
1-Month Change | -16.22% | ||
1-Year Change | -5.83% | ||
3-Year Change | 19.00% | ||
5-Year Change | -81.78% | ||
Fundamentals | |||
Shares Outstanding | 57.2M | ||
Total Assets | $179.5M | ||
Market Cap | $286.5M | ||
Enterprise Value | $245.3M | ||
Period: QTR TTM FY | |||
Revenue | $1.4M | ||
Net Income | -$20.2M | ||
Free Cash Flow | -$18.0M | ||
EBIT | -$19.6M | ||
EBITDA | -$18.9M | ||
Net Working Capital | $139.8M | ||
EPS | -$0.35 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | 181 | ||
P/B | 2 | ||
P/E | -14 | ||
PEG | 1 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 07/05/2022 | ||
Earnings & Revenue